LEADER 00000cam  2200000 a 4500 
001    ocm45538443 
003    OCoLC 
005    20040805000000.0 
008    001115t20002000dcua     b    101 0 eng   
010       99073693 
016 7  100971023|2DNLM 
020    0875532497 
035    (OCoLC)45538443 
040    NLM|beng|cNLM|dCUY|dCUX|dMUQ|dONU|dOCLCQ|dNNF 
042    nlmcopyc 
049    STJJ 
050  4 RA1242.N5|bN54 2000 
060 00 2000 M-865 
060 10 WM 290|bN66195 2000 
092    616.865|bN662 
245 00 Nicotine and public health /|cedited by Roberta Ferrence 
       .. [and others].. 
264  1 Washington, DC :|bAmerican Public Health Association,
       |c[2000] 
264  4 |c©2000 
300    xxii, 512 pages :|billustrations ;|c26 cm 
336    text|btxt|2rdacontent 
337    unmediated|bn|2rdamedia 
338    volume|bnc|2rdacarrier 
504    Includes bibliographical references and index. 
505 0  Part 1: Nicotine in context. Origins of nicotine use and 
       the global diffusion of tobacco / Alexander von Gernet -- 
       Some lessons from the history of American tobacco 
       advertising and its regulations in the 20th century / Lynn
       T. Kozlowski -- Control systems for psychoactive 
       substances / Robin Room ; commentary, Eric Single -- Part 
       II: Effects of nicotine. Nicotine toxicity / Neal L. 
       Benowitz -- Effects of nicotine during pregnancy / Cheryl 
       A. Oncken -- Cognitive and behavioral effects of nicotine 
       / Stephen J. Heishman ; commentary, Robert West -- Part 
       III: Nicotine dependence and delivery. Nicotine as an 
       addictive substance / Harold Kalant ; commentary, John 
       Hughes -- Today's cigarettes: steps toward reducing the 
       health impact / William Rickert -- Snuff: an alternative 
       nicotine delivery system / Lars M. Ramström -- Cigars, 
       pipes, and other traditional tobacco products / Donald 
       Shopland -- Nicotine-replacement therapies / Karl Olov 
       Fagerström -- Innovative nicotine delivery devices from 
       tobacco companies / John Slade -- Nicotine delivery 
       systems: implications for abuse potential, medications 
       development, and public health / Jack E. Henningfield and 
       Reginald V. Fant ; commentary, John Pinney -- Establishing
       a nicotine threshold for addiction / Neal L. Benowitz and 
       Jack E. Henningfield -- Public health and levels of 
       nicotine: should nicotine levels in cigarettes by 
       minimized or maximized? / Michael A.H. Russell -- Part IV:
       Current and potential patterns of use. Contemporary 
       patterns of nicotine use in Canada and the United States /
       Roberta Ferrence, Shelley Lothian, and Deanna Cape ; 
       commentary, John Pierce -- Past trends in tobacco use and 
       some thoughts on future trends / Susan J. Bondy, Joanna E.
       Cohen, and Jürgen T. Rehm ; commentary, Peter Reuter -- 
       Part V: Policy and health issues. Regulatory mechanisms 
       for nicotine delivering products: marketing and 
       competition issues / David T. Sweanor ; commentary, Matt 
       Myers, Richard Daynard, Ron Stewart -- What can advocates 
       of nicotine-replacement therapies learn from the 
       experience in introducing methadone treatment? / Peter 
       Reuter -- Clinical implications of long-term nicotine use 
       / Richard D. Hurt ; commentary, David T. Sweanor -- The 
       emerging market for long-term nicotine maintenance / 
       Kenneth E. Warner, John Slade, and David T. Sweanor -- The
       public health implications of adopting a harm-reduction 
       approach to nicotine / Christiane Poulin -- Part VI: 
       Implications for research and policy. An agenda for 
       experimental research / William A. Corrigall -- Agendas 
       for regulation and monitoring of nicotine and tobacco / 
       Neil Collishaw ; commentary, Tom Stephens, Fred Ashbury --
       Final panel: Building a public health agenda for nicotine 
       / commentary, Kenneth E. Warner, Greg Connolly, Nigel Gray
       -- Part VII: Recommendations for policy. The role of 
       managing nicotine in controlling the tobacco epidemic / 
       John Slade ... [et al.] -- APHA mission statement. 
650  0 Nicotine|xPhysiological effect. 
650  0 Nicotine|xToxicology. 
650  0 Smoking. 
650 12 Nicotine|xadverse effects|zCanada|vCongresses. 
650 12 Tobacco Use Disorder|zCanada|vCongresses. 
650 22 Public Health|zCanada|vCongresses. 
700 1  Ferrence, Roberta G. 
710 2  American Public Health Association. 
994    90|bSTJ